FDAFDA · Food and drugs·Recall number D-1604-2020
Nature-Throid, Thyroid USP [liothyronine (T3) 22.5 mcg and levothyroxine (T4) 95 mcg], 2.5 Grain (162.5 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3310-4; b) 60-count bottles, NDC 64727-3310-5; c) 90-count bottles, NDC 64727-3310-6; d) 100-count bottles, NDC 64727-3310-1; and e) 1,000-count bottles, NDC 64727-3310-2; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034.
Published September 23, 2020 · Recall initiated: August 25, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Manufacturer
- RLC Labs Inc.
- Distributor
- Nationwide in the United States
- Lot
- All lots with expiry between 10/2020-07/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.